Your browser doesn't support javascript.
loading
Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.
Hiesinger, William; Frederick, John R; Atluri, Pavan; McCormick, Ryan C; Marotta, Nicole; Muenzer, Jeffrey R; Woo, Y Joseph.
Afiliación
  • Hiesinger W; Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
J Thorac Cardiovasc Surg ; 140(5): 1174-80, 2010 Nov.
Article en En | MEDLINE | ID: mdl-20951261
OBJECTIVES: Stromal cell-derived factor (SDF)-1α is a potent endogenous endothelial progenitor cell (EPC) chemokine and key angiogenic precursor. Recombinant SDF-1α has been demonstrated to improve neovasculogenesis and cardiac function after myocardial infarction (MI) but SDF-1α is a bulky protein with a short half-life. Small peptide analogs might provide translational advantages, including ease of synthesis, low manufacturing costs, and the potential to control delivery within tissues using engineered biomaterials. We hypothesized that a minimized peptide analog of SDF-1α, designed by splicing the N-terminus (activation and binding) and C-terminus (extracellular stabilization) with a truncated amino acid linker, would induce EPC migration and preserve ventricular function after MI. METHODS: EPC migration was first determined in vitro using a Boyden chamber assay. For in vivo analysis, male rats (n = 48) underwent left anterior descending coronary artery ligation. At infarction, the rats were randomized into 4 groups and received peri-infarct intramyocardial injections of saline, 3 µg/kg of SDF-1α, 3 µg/kg of spliced SDF analog, or 6 µg/kg spliced SDF analog. After 4 weeks, the rats underwent closed chest pressure volume conductance catheter analysis. RESULTS: EPCs showed significantly increased migration when placed in both a recombinant SDF-1α and spliced SDF analog gradient. The rats treated with spliced SDF analog at MI demonstrated a significant dose-dependent improvement in end-diastolic pressure, stroke volume, ejection fraction, cardiac output, and stroke work compared with the control rats. CONCLUSIONS: A spliced peptide analog of SDF-1α containing both the N- and C- termini of the native protein induced EPC migration, improved ventricular function after acute MI, and provided translational advantages compared with recombinant human SDF-1α.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Células Madre / Cardiotónicos / Movimiento Celular / Función Ventricular Izquierda / Células Endoteliales / Quimiocina CXCL12 / Infarto del Miocardio Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Thorac Cardiovasc Surg Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Células Madre / Cardiotónicos / Movimiento Celular / Función Ventricular Izquierda / Células Endoteliales / Quimiocina CXCL12 / Infarto del Miocardio Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Thorac Cardiovasc Surg Año: 2010 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos